About this trial
Up to 20% of MV patients experience EF \[10\]. EF is defined as the need to reinsert the endotracheal tube to resume MV in patients extubated for less than 48 hours. It has high rates of morbidity and mortality, prolongs the duration of MV and thus causes a longer stay in the PICU and risk of complications such as the need for tracheostomy, the incidence of pneumonia and pulmonary damage, and finally, costs increase as well and death \[10, 11\] .
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patient at PICU < 18 years subjected to MV through an endotracheal tube at least >12 hours.
Patients eligible for weaning from MV according to the weaning criteria (Evidence for some reversal of the underlying cause following for respiratory failure, Adequate oxygenation" PaO2/FIO2 ratio ≥ 200, FIO2 ≤ 0.40, PaO2 ≥ 60, PaCO2 ≤ 60 and PEEP ≤ 5 cmH2O.", PH ≥ 7.25, Respiratory rate (RR) ≤ 45 bpm, Heart rate (HR) ≤ 140 bpm,(rapid shallow breathing index = tidal volume / RR) RSBI ≤ 8 breaths/min/ml/kg body weight, Hemodynamic stable, no or minimal vasopressor or inotropes"[1,12],.
Appropriate level of consciousness, No continuous sedation infusion nor neuromuscular blocking agents, afebrile, adequate hemoglobin ≥ 7.5 g/dl and/or no evidence of hemorrhage.
Disqualifiers
Patients less than 30 days.
Tracheostomized patients.
Death on mv ≤ 12 hours.
Unplanned extubation.
Trial population
Patients in PICUS in Sohag University Hospitals.
Trial design
Case-control
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
successful extubation and weaning from mechanical ventilation
passing spontaneous trial and air leak test and not requiring to be re-intubated within 2 days
failed extubation , failed weaning from mechanical ventilation
not passing spontaneous trial and air leak test and not requiring to be re-intubated within 2 days
Secondary outcomes
survival or death
weaning from mechanical ventilation and improvement of the cause of intubation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.